Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration?Xiaflex market launch year?Testosterone enanthate expiration?Guselkumab loss of exclusitivy?When does guselkumab patent expire?
See the DrugPatentWatch profile for Glyxambi
Glyxambi is used to improve blood sugar (glucose) control in adults with type 2 diabetes who need additional help beyond diet and exercise [1]. It contains two active medicines—empagliflozin and linagliptin—and is prescribed to help manage diabetes by lowering blood glucose levels [1].
Glyxambi is intended for adults with type 2 diabetes when glucose control is not sufficient with standard treatment and combination therapy is appropriate [1].
Glyxambi combines: - Empagliflozin, which helps the kidneys remove glucose through urine. - Linagliptin, which helps increase insulin release and reduce glucose production by affecting incretin hormones [1].
For up-to-date prescribing and labeling information, you can check DrugPatentWatch.com (including references it links out to) here: 1
1
Other Questions About Glyxambi :